Sign In
Buy AIM
$0.732
-0.0947 (-11.46%)
At Close: Jun 03, 2026
AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment
08:00am, Friday, 27'th Sep 2024
Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, October 2nd at 4:00 PM ET Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on
Jersey Oil & Gas CEO says GBA deals are ‘testament to asset quality', now eyes opportunities outside UK
03:37am, Thursday, 19'th Sep 2024
Jersey Oil and Gas PLC (AIM:JOG, OTC:JYOGF) chief executive Andrew Benitz, in today's interim results statement, highlighted February's farm-out to Serica Energy as testament to the quality of the GBA
Optima Health to list on AIM in September after separation from Marlowe
03:57am, Thursday, 12'th Sep 2024
Occupational health specialist Optima Health PLC will begin life as a stand-alone company on the AIM section of the London Stock Exchange later this month after being spun out of Marlow PLC. The Gla
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATE
Data demonstrate compelling evidence of the immune-stimulatory properties linked to TLR-3 activation through Ampligen Additional commentary published discussing the potential of Ampligen and two other
AIM ImmunoTech Inc. (AIM) Q2 2024 Earnings Call Transcript
11:13am, Friday, 16'th Aug 2024
AIM ImmunoTech Inc. (NYSE:AIM ) Q2 2024 Earnings Conference Call August 16, 2024 8:30 AM ET Company Participants Thomas Equels - Chief Executive Officer, President & Executive Vice Chairman Christophe
AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate Update
07:00am, Friday, 16'th Aug 2024
– Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications
Aimia Inc. (AIMFF) Q2 2024 Earnings Call Transcript
01:42pm, Tuesday, 13'th Aug 2024
Aimia Inc. (OTCPK:AIMFF) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Joe Racanelli - Investor Relations Tom Finke - Executive Chairman Steve Leonard - President &
AIM ImmunoTech to Discuss Second Quarter 2024 Financial Results on August 16, 2024, and Host Conference Call and Webcast
09:05am, Tuesday, 13'th Aug 2024
OCALA, Fla., Aug. 13, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), announced today that management will host a conference call and webcast to di
Movers: Seeing Machines continues to impress as it moves past the 2m mark
02:27am, Saturday, 10'th Aug 2024
Why is AIM so terrible at recognising potential, let alone putting a realistic value on it – even as it is crystallising? A case in point: Seeing Machines Ltd (AIM:SEE, OTC:SEEMF) (up 7% this week).
Hermes Pacific sinks as AIM delisting announced
04:02am, Thursday, 08'th Aug 2024
Hermes Pacific Investment's shares sank 23% on news of the property-focused investment company's planned delisting from AIM. Hermes Pacific has struggled to find attractive opportunities in the recent
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
09:15am, Monday, 29'th Jul 2024
OCALA, Fla., July 29, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company
AIM Announces New Positive Data on Ampligen's Anti-Tumor Potential When Used as Part of a Combination Therapy
08:50am, Wednesday, 24'th Jul 2024
OCALA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of new pre-clinical data concerning the compan
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
08:55am, Wednesday, 03'rd Jul 2024
OCALA, Fla., July 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the next CEO Corner segment has been published on the Company'
Phoenix Copper lists $110mln of corporate copper bonds on TISE
03:27am, Monday, 01'st Jul 2024
Phoenix Copper Ltd (AIM:PXC, OTCQX:PXCLF) highlighted to investors that US$110 million of corporate copper bonds have been admitted to trading on the official list of the International Stock Exchange
